Ricky Mulvey: Let's talk about a company that was founded in 1876 that, Bill, is looking a lot like a growth stock. Eli Lilly reported ... don't come to me with a pitch, come to me with a poster ...

Only time will tell whether I'm right, but there's a compelling pitch for each stock ... It competes primarily with Eli Lilly, which owns an estimated 34% of the market. Research from Grand ...

Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...

Eli Lilly (LLY) closed the latest trading day at $822.27, indicating a -0.22% change from the previous session's end. This change lagged the S&P 500's daily gain of 0.49%. Elsewhere, the Dow lost ...

or is Lilly stock still a buy? Let's find out. Image source: Getty Images. What's behind Lilly's double-digit revenue growth So, first let's talk about the Eli Lilly story so far. It's important ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of ...

Now the question is: Is it too late to get in on this weight loss giant, or is Lilly stock still a buy? Let's find out. So, first let's talk about the Eli Lilly story so far. It's important to ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...